Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Michael Gong, MD, PhD

216.444.5600

Michael Gong, MD, PhD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.4951
WorkFax:216.636.4492
Michael Gong, MD, PhD
Department: Urology
Location: Hillcrest Hospital
Mail Code HC20
6770 Mayfield Road
Mayfield Heights, OH 44124
WorkAppointment:216.444.5600
DeskDesk:440.461.6430
WorkFax:216.636.4492
Michael Gong, MD, PhD
Department: Taussig Cancer Institute
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.4951
WorkFax:216.636.4492
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Michael C. Gong, MD, PhD, is a staff physician in the Glickman Urological and Kidney Institute and Director of Urologic Oncology at Hillcrest Hospital. He specializes in cancer of the kidney, prostate, and bladder.  He is a board-certified urologist and a highly skilled robotic and laparoscopic surgeon.  He is a member of the American Urologic Association and the American Society of Clinical Oncology.

Dr. Gong graduated from Pritzker School of Medicine at the University of Chicago. He completed his residency in urology at Stanford University Medical Center in California and his fellowship training at Memorial Sloan-Kettering Cancer Center in New York. He was appointed to Cleveland Clinic in 2007.

Dr. Gong was recognized as the American Foundation for Urologic Disease Research Scholar and received the Medical Scientist Training Program Scholarship.  He also serves as a reviewer for the Journal of Urology.

Dr. Gong conducts research in the detection and treatment of prostate cancer, minimally invasive surgical approaches to bladder cancer, and the surgical management of advanced renal cell carcinoma.

Describing his philosophy about patient care, Dr. Gong says: “A patient is often faced with anxiety and uncertainty of disease management and outcomes. A physician should compassionately guide the patient through treatment decisions and tailor clinical management to individual needs.

"I appreciate the opportunity to participate in clinical care and strive to educate each patient and address their problems and concerns. As important, I also truly enjoy another side of medicine, the ability to establish long-term relationships with patients and their families.”

Education & Fellowships

Fellowship - Memorial Sloan-Kettering Cancer Center
Urologic Oncology
New York, NY USA
1999
Residency - Stanford University Hospital
Urology
Stanford, CA USA
1996
Residency - Stanford University Hospital
General Surgery
Stanford, CA USA
1992
Internship - Stanford University Hospital
General Surgery
Stanford, CA USA
1991
Medical School - University of Chicago Pritzker School of Medicine
Chicago, IL USA
1990
Doctorate - University of Chicago Pritzker School of Medicine
Chicago, IL USA
1989
Undergraduate - University of Chicago
Chicago, IL USA
1983

Certifications

  • Urology

Specialty Interests

Bladder Cancer, Kidney Cancer, Prostate Cancer, Robotic and Laparoscopic Surgery, Laparoscopic Surgery, Robotic Surgery, Testis Cancer

Memberships

  • American Urological Association

Treatment & Services

  • Laparoscopic Prostate Surgery
  • Laparoscopic Surgery
  • Partial Nephrectomy
  • Radical Cystectomy
  • Radical Nephrectomy: Laparoscopic Or Open
  • Retroperitoneal Lymph Node Dissection
  • Robotic Prostate Surgery
  • Robotic Prostatectomy
  • Urology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/17/2014, Dr. Gong has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English